Načítá se...
CDX2 - Linking Cell and Patient Fates in Colon Cancer
Administering adjuvant chemotherapy to stage II colon cancer patients is controversial due to poor benefit observed for the population as a whole. Recently, Dalerba et al identified a subgroup of stage II patients that might benefit from adjuvant chemotherapy based on lack of CDX2 expression in thei...
Uloženo v:
| Vydáno v: | Cell Stem Cell |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5497577/ https://ncbi.nlm.nih.gov/pubmed/26849302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stem.2016.01.011 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|